DCX and Alzheimer disease: In this regard, Moreno-Jiménez and co-workers (2019) [44] have reported progressively reduced numbers of DCX+ cells and an impairment in the maturation of these cells in AD patients who are at the earliest Braak stages, even before amyloid plaques and NFTs are present.